SPDR S&P Pharmaceuticals ETF
XPH
XPH
68 hedge funds and large institutions have $167M invested in SPDR S&P Pharmaceuticals ETF in 2016 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 17 increasing their positions, 23 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.97% more ownership
Funds ownership: 32.08% → 33.05% (+0.97%)
26% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 23
Holders
68
Holding in Top 10
–
Calls
$1.13M
Puts
$334K
Top Buyers
| 1 | +$4.86M | |
| 2 | +$1.87M | |
| 3 | +$1.81M | |
| 4 |
SI
Stephens Inc
Little Rock,
Arkansas
|
+$1.63M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$1.58M |
Top Sellers
| 1 | -$4.18M | |
| 2 | -$3.21M | |
| 3 | -$1.33M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.22M |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$986K |